Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus
J Brun(University of Ottawa), David F. Stojdl(Ottawa Regional Cancer Foundation), Harold Atkins(University of Ottawa), J. Andrea McCart(Toronto General Hospital), John C. Bell(Ottawa Hospital), Theresa Falls(Ottawa Hospital), Dan C. McManus(University of Ottawa), Kang Hu(Ottawa Hospital), Charles Lefebvre(Children's Hospital of Eastern Ontario), Douglas J. Mahoney(University of Calgary)
Cited by 158
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
|The Lancet Oncology|2008|522
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419